Table 1.
Characteristics of the cross-sectional studies included in this systematic review.
| Num | Author/Study | With treatment (surgical), n (%) | Follow-up (mo) | Without treatment (control), n (%) | Follow-up (mo) | Gastric cancer stages, n (%) | ||
|---|---|---|---|---|---|---|---|---|
| Survival | Death | Survival | Death | |||||
| 1 | Oñate-Ocaña, et al (2007). Treatment of the adenocarcinoma of the esophagogastric junction at a single institution in Mexico | 29 (42.65) | 39 (57.35) | 16 | 10 (6.02) | 156 (93.98) | 6 | I: 23 (9.8), II: 84 (35.9); III: 109 (46.6); UND: 18 (7.7) |
| 2 | Green, et al (2002). Adenocarcinoma of the stomach: univariate and multivariate analysis of factors associated with survival | 38 (33.33) | 76 (66.67) | 12 | 10 (27.77) | 26 (72.23) | 6 | I: 8 (5.3), II: 9 (6), III: 33 (22.0); IV: 96 (64.0); UND: 4 (2.4) |
| 3 | Ramos de la Medina, et al (2004). Clinicopathologic characteristics of gastric cancer in a young patient population | 31 (42.46) | 42 (57.54) | 10 | 6 (60.0) | 4 (40.0) | 6 | I–II: 8 (9.6), III: 22 (26.5); IV: 53 (63.9) |
| 4 | Medina-Franco, et al (2007). Prognostic factors in primary gastric lymphoma | 16 (80.00) | 4 (20.00) | 65 | 11 (52.38) | 10 (47.62) | 18 | I: 11 (26.8); II: 8 (19.5); III: 7 (17.1); IV: 15 (36.6) |
| 5 | Oñate-Ocaña, et al (2008). Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma | 27 (15.97) | 142 (84.03) | 25 | 52 (9.47) | 497 (90.53) | 8 | III: 86 (12.0); IV: 632 (88.0) |
UND = undefined stage.